Creative Biolabs-Immuno-oncology

Anti-LGALS1 (clone 32E8P7J) SynExpress T7-G-I17-X Modified CD8+ T cells (CAT#: ITS-1224-CR2008)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target LGALS1 (clone 32E8P7J). We employs the HBV (T7-GFP-IL-17-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Rabbit
Target
LGALS1
Clone
32E8P7J
Species Reactivity
Cattle; Human; Mouse; Pig; Rat
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-17
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.87
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.